{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T22:35:51Z","timestamp":1789079751565,"version":"build-2803163510"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The global aging population faces a disproportionate burden of lung cancer, creating an urgent need for minimally invasive screening methods. Liquid biopsy-based DNA methylation testing, particularly targeting the cysteine dioxygenase type 1 (CDO1) gene promoter, has emerged as a promising approach for early cancer detection. This study aims to systematically evaluate the diagnostic value of CDO1 promoter methylation in lung cancer using liquid biopsies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A comprehensive literature search was conducted across PubMed\/MEDLINE, Embase, Web of Science, and Cochrane Library from inception to 28Th September, 2025. Studies reporting CDO1 promoter methylation in liquid biopsies (blood, urine, or sputum) for lung cancer detection with histological confirmation were included. Methodological quality was assessed using QUADAS-2. Bivariate random-effects models were used to calculate pooled sensitivity, specificity, diagnostic odds ratio (DOR), positive\/negative likelihood ratios (PLR\/NLR), and 95% confidence intervals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Seven studies involving 655 lung cancer cases and 402 controls were included. CDO1 methylation demonstrated pooled sensitivity of 0.72 and specificity of 0.89 for blood-based liquid biopsies, and 0.66 and 0.87 for non-blood specimens, respectively. The overall diagnostic odds ratio was 19.13 (95% CI: 13.53-26.84), with positive and negative likelihood ratios of 7.73 (95% CI: 5.77-10.35) and 0.32 (95% CI: 0.26-0.39). No significant heterogeneity was observed across studies (I\u00b2 = 0% for all parameters). Subgroup analyses revealed consistent performance across different specimen types and geographic regions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>CDO1 promoter methylation detection in liquid biopsies shows robust diagnostic accuracy for lung cancer, with performance characteristics supporting its potential clinical utility, particularly for older populations who face barriers to conventional screening. The consistency across diverse specimen types and populations underscores its promise as a minimally invasive screening tool.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2025.1739963","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T05:42:26Z","timestamp":1768196546000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Utility and clinical effectiveness of liquid biopsy-based DNA methylation testing in early tumor screening and diagnosis, emphasizing older adult populations: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"15","author":[{"given":"Yujuan","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desheng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.02615","article-title":"Using circulating tumor DNA in colorectal cancer: current and evolving practices","volume":"40","author":"Malla","year":"2022","journal-title":"J Clin Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241411715","article-title":"DNA methylation in the fields of prenatal diagnosis and early detection of cancers","volume":"24","author":"Copped\u00e8","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-024-01386-5","article-title":"DNA demethylation triggers cell free DNA release in colorectal cancer cells","volume":"16","author":"Pessei","year":"2024","journal-title":"Genome Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e2401760","DOI":"10.1002\/advs.202401760","article-title":"Performance of liquid biopsy-based multi-omics biomarkers for early detection of gynecological Malignancies: A prospective study (PERCEIVE-I)","volume":"12","author":"Feng","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-bioeng-110222-111259","article-title":"Liquid biopsy based on cell-free DNA and RNA","volume":"26","author":"Loy","year":"2024","journal-title":"Annu Rev BioMed Eng"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e2206518","DOI":"10.1002\/advs.202206518","article-title":"Multiplex digital methylation-specific PCR for noninvasive screening of lung cancer","volume":"10","author":"Zhao","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20153825","article-title":"Liquid biopsy as a tool for differentiation of leiomyomas and sarcomas of corpus uteri","volume":"20","author":"Dvorsk\u00e1","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23073774","article-title":"A liquid biopsy-based approach for monitoring treatment response in post-operative colorectal cancer patients","volume":"23","author":"Bart\u00e1k","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/biom14121634","article-title":"Research progress of liquid biopsy based on DNA methylation in tumor diagnosis and treatment","volume":"14","author":"Bao","year":"2024","journal-title":"Biomolecules"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyac204","article-title":"Mutation-agnostic detection of colorectal cancer using liquid biopsy-based methylation-specific signatures","volume":"28","author":"Gouda","year":"2023","journal-title":"Oncologist"},{"key":"B11","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s40364-023-00528-y","article-title":"Diagnosing and monitoring pancreatic cancer through cell-free DNA methylation: progress and prospects","volume":"11","author":"Garc\u00eda-Ortiz","year":"2023","journal-title":"biomark Res"},{"key":"B12","doi-asserted-by":"publisher","first-page":"594","DOI":"10.21037\/tlcr-22-742","article-title":"Current and future applications of liquid biopsy in non-small-cell lung cancer-a narrative review","volume":"12","author":"Tomasik","year":"2023","journal-title":"Transl Lung Cancer Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16112001","article-title":"Current challenges of methylation-based liquid biopsies in cancer diagnostics","volume":"16","author":"Rendek","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcp.2022.101871","article-title":"The application of circulating tumor cell and cell-free DNA liquid biopsies in ovarian cancer","volume":"66","author":"Balla","year":"2022","journal-title":"Mol Cell Probes"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14163954","article-title":"Combined liquid biopsy methylation analysis of CADM1 and MAL in cervical cancer patients","volume":"14","author":"Leffers","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3779\/j.issn.1009-3419.2020.102.20","article-title":"The role of plasma CDO1 methylation in the early diagnosis of lung cancer","volume":"23","author":"Wang","year":"2020","journal-title":"Zhongguo Fei Ai Za Zhi = Chin J Lung Cancer"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-2896","article-title":"Detection of promoter DNA methylation in urine and plasma aids the detection of non-small cell lung cancer","volume":"26","author":"Liu","year":"2020","journal-title":"Clin Cancer Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"4","DOI":"10.19338\/j.issn.1672-2019.2017.08.002","article-title":"Detection of cysteine dioxygenase 1 promoter hypermethylation in lung adenocarcinoma using tissue and serum samples","volume":"25","author":"Chen","year":"2017","journal-title":"China Med Eng"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2024.39.e28","article-title":"Combination analysis of PCDHGA12 and CDO1 DNA methylation in bronchial washing fluid for lung cancer diagnosis","volume":"39","author":"Park","year":"2024","journal-title":"J Korean Med Sci"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2022.06.013","article-title":"Detection of non-metastatic non-small-cell lung cancer in urine by methylation-specific PCR analysis: A feasibility study","volume":"170","author":"Wever","year":"2022","journal-title":"Lung Cancer"},{"key":"B21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13148-020-00828-2","article-title":"Ultrasensitive DNA hypermethylation detection using plasma for early detection of NSCLC: a study in Chinese patients with very small nodules","volume":"12","author":"Chen","year":"2020","journal-title":"Clin Epigenetics"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1158\/1078-0432.CCR-16-1371","article-title":"Early detection of lung cancer using DNA promoter hypermethylation in plasma and sputum","volume":"23","author":"Hulbert","year":"2017","journal-title":"Clin Cancer Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s00345-025-05728-9","article-title":"Liquid biopsy for promoter methylation in prostate cancer: a promising non-invasive diagnostic weapon","volume":"43","author":"Han","year":"2025","journal-title":"World J Urol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-1181","article-title":"ESR1 methylation: A liquid biopsy-based epigenetic assay for the follow-up of patients with metastatic breast cancer receiving endocrine treatment","volume":"24","author":"Mastoraki","year":"2018","journal-title":"Clin Cancer Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14020462","article-title":"Comprehensive Approach to Distinguish Patients with Solid Tumors from Healthy Controls by Combining Androgen Receptor Mutation p.H875Y with Cell-Free DNA Methylation and Circulating miRNAs","volume":"14","author":"Tomeva","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.cancergen.2025.04.001","article-title":"Analytical validation of the Belay Vantage\u2122 assay for evaluation of MGMT promoter methylation using enzymatically converted tumorDNA from cerebrospinal fluid","author":"Schilter","year":"2025","journal-title":"Cancer Genet"},{"key":"B27","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s13148-019-0757-3","article-title":"Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer-a clinical biomarker discovery and validation study","volume":"11","author":"Jensen","year":"2019","journal-title":"Clin Epigenetics"},{"key":"B28","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.trecan.2019.12.006","article-title":"Diagnostic power of DNA methylation classifiers for early detection of cancer","volume":"6","author":"Roy","year":"2020","journal-title":"Trends Cancer"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e0278108","DOI":"10.1371\/journal.pone.0278108","article-title":"Kidney tumors associated with germline mutations of FH and SDHB show a CpG island methylator phenotype (CIMP)","volume":"17","author":"Ricketts","year":"2022","journal-title":"PloS One"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14010204","article-title":"Emerging biomarkers in thyroid practice and research","volume":"14","author":"Agarwal","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25063502","article-title":"Use of enzymatically converted cell-free DNA (cfDNA) data for copy number variation-linked fragmentation analysis allows for early colorectal cancer detection","volume":"25","author":"\u010cerno\u0161a","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.2174\/1389450118666170911114342","article-title":"Epigenetic biomarkers for risk assessment of particulate matter associated lung cancer","volume":"19","author":"Bhargava","year":"2018","journal-title":"Curr Drug Targets"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.14252","article-title":"5-Hydroxymethylcytosine profiling from genomic and cell-free DNA for colorectal cancers patients","volume":"23","author":"Gao","year":"2019","journal-title":"J Cell Mol Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1039\/d1an00345c","article-title":"e-MagnetoMethyl IP: a magnetic nanoparticle-mediated immunoprecipitation and electrochemical detection method for global DNA methylation","volume":"146","author":"Farhana","year":"2021","journal-title":"Analyst"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12102880","article-title":"Non-invasive early molecular detection of gastric cancers","volume":"12","author":"Yamamoto","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e0285214","DOI":"10.1371\/journal.pone.0285214","article-title":"Isolation of salivary cell-free DNA for cancer detection","volume":"18","author":"Brooks","year":"2023","journal-title":"PloS One"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noac264","article-title":"Cerebrospinal fluid methylome-based liquid biopsies for accurate Malignant brain neoplasm classification","volume":"25","author":"Zuccato","year":"2023","journal-title":"Neuro Oncol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.canlet.2021.03.014","article-title":"True conversions from RAS mutant to RAS wild-type in circulating tumor DNA from metastatic colorectal cancer patients as assessed by methylation and mutational signature","volume":"507","author":"Nicolazzo","year":"2021","journal-title":"Cancer Lett"},{"key":"B39","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13148-024-01708-9","article-title":"Quantification method of ctDNA using cell-free DNA methylation profile for noninvasive screening and monitoring of colon cancer","volume":"16","author":"Ryu","year":"2024","journal-title":"Clin Epigenetics"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-025-04813-7","article-title":"Liquid biopsy based on multi-targeted capture of urinary tumor DNA combined with machine learning to detect urothelial carcinoma: a multicenter prospective study","author":"Tang","year":"","journal-title":"Int Urol Nephrol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.3390\/ijms22052654","article-title":"Liquid biopsies in the clinical management of germ cell tumor patients: state-of-the-art and future directions","volume":"22","author":"Lobo","year":"2021","journal-title":"Int J Mol Sci"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1739963\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T05:42:33Z","timestamp":1768196553000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1739963\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":41,"alternative-id":["10.3389\/fonc.2025.1739963"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1739963","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"article-number":"1739963"}}